Insulin Nazal Spray Could Help With Alzheimer Symptoms
A study conducted by Wake Forest Baptist Medical Center reported that a nasal spray which contains manufactured insulin can help with certain cognitive impairments associated with Alzheimer’s disease.
The drug can have positive effects on both older adults who suffer from mild cognitive impairment also called MCI or mild and moderate Alzheimer’s dementia. The study noticed improvement in both these conditions after a group of patients received the nasal solution for 21 days. Groups of patients who received larger doses of the drug which was named insulin detemir had significantly better results than those who got the standard dose.
The higher doses of the drug also helped patients who had the Alzheimer related gene APOE-e4. They managed to get much higher memory scores than patients who took a placebo pill or the standard dosage.
Suzanne Craft, gerontology and geriatric professor at the Wake Forest Baptist and lead author of the study declared that the registered results are evidence that insulin detemir can be a functional treatment for people who have Alzheimer’s related dementia or mild cognitive impairment. She also added that improving memory skills for people with the APOE-e4 gene was also a huge success as they can be some of the most resistant to any form of treatment.
Craft also declared that although there were basically no adverse reactions further testing is needed in order to precisely determine the “efficacy and safety” of the treatment.